| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
67,395 |
58,855 |
$3.98M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
33,748 |
33,434 |
$3.02M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
39,418 |
14,465 |
$2.92M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
33,588 |
18,533 |
$1.43M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,038 |
9,296 |
$909K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
39,155 |
14,235 |
$811K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,606 |
5,593 |
$775K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
9,887 |
9,795 |
$609K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,511 |
7,584 |
$231K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
37,679 |
35,399 |
$230K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,479 |
5,217 |
$191K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13,046 |
6,667 |
$180K |
| 87070 |
|
23,770 |
22,069 |
$178K |
| 87184 |
|
23,433 |
21,747 |
$134K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
11,676 |
6,120 |
$128K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,065 |
1,987 |
$96K |
| 12001 |
|
1,040 |
1,034 |
$84K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,112 |
2,232 |
$71K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,817 |
2,779 |
$62K |
| S9083 |
Global fee urgent care centers |
423 |
341 |
$44K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
453 |
452 |
$38K |
| 10060 |
|
374 |
369 |
$36K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
348 |
347 |
$29K |
| 71046 |
Radiologic examination, chest; 2 views |
1,210 |
1,181 |
$29K |
| 93000 |
|
1,686 |
1,667 |
$29K |
| 10061 |
|
200 |
194 |
$25K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
220 |
215 |
$25K |
| 29125 |
|
360 |
360 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,427 |
1,414 |
$21K |
| 10120 |
|
128 |
128 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
183 |
183 |
$17K |
| 73630 |
|
799 |
792 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
14,076 |
13,619 |
$15K |
| 73110 |
|
583 |
578 |
$14K |
| 90707 |
|
182 |
180 |
$12K |
| 11730 |
|
191 |
177 |
$12K |
| 73140 |
|
543 |
541 |
$11K |
| 99342 |
|
570 |
570 |
$11K |
| 90686 |
|
906 |
905 |
$10K |
| 81000 |
|
3,124 |
3,025 |
$10K |
| 94760 |
|
71,491 |
65,448 |
$10K |
| 99215 |
Prolong outpt/office vis |
76 |
76 |
$10K |
| 92587 |
|
282 |
280 |
$9K |
| 90715 |
|
242 |
242 |
$9K |
| 73610 |
|
423 |
421 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
496 |
394 |
$7K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
930 |
914 |
$7K |
| 92585 |
|
67 |
67 |
$7K |
| 36410 |
|
666 |
627 |
$7K |
| 73130 |
|
308 |
308 |
$6K |
| 12011 |
|
57 |
57 |
$6K |
| 90674 |
|
262 |
262 |
$5K |
| 69210 |
|
115 |
114 |
$5K |
| 12002 |
|
44 |
44 |
$4K |
| 29131 |
|
89 |
89 |
$4K |
| 29515 |
|
57 |
57 |
$4K |
| 29540 |
|
219 |
190 |
$4K |
| 73090 |
|
179 |
178 |
$3K |
| 73080 |
|
144 |
138 |
$3K |
| 99050 |
|
696 |
670 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
124 |
124 |
$2K |
| 90461 |
|
115 |
114 |
$2K |
| 90656 |
|
94 |
94 |
$2K |
| 99201 |
|
35 |
35 |
$1K |
| 17110 |
|
17 |
16 |
$1K |
| 73590 |
|
78 |
78 |
$1K |
| 81025 |
|
423 |
416 |
$1K |
| 99383 |
|
13 |
13 |
$1K |
| 85018 |
|
562 |
558 |
$1K |
| E0116 |
Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each |
81 |
81 |
$1K |
| 0031A |
|
23 |
23 |
$952.86 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$894.21 |
| 90658 |
|
495 |
494 |
$826.71 |
| 29126 |
|
12 |
12 |
$735.32 |
| 99442 |
|
19 |
19 |
$654.04 |
| V5008 |
Hearing screening |
35 |
35 |
$620.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
56 |
56 |
$582.50 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
108 |
107 |
$543.70 |
| 99441 |
|
13 |
13 |
$539.37 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
43 |
31 |
$537.94 |
| 11721 |
|
28 |
28 |
$512.90 |
| 73552 |
|
15 |
15 |
$407.80 |
| 90734 |
|
12 |
12 |
$300.00 |
| 73660 |
|
13 |
13 |
$244.79 |
| 82947 |
|
62 |
50 |
$242.78 |
| 99173 |
|
123 |
123 |
$211.07 |
| 87430 |
|
12 |
12 |
$71.49 |
| 99051 |
|
16 |
13 |
$17.85 |
| 94664 |
|
26 |
26 |
$16.23 |
| 99000 |
|
673 |
543 |
$9.46 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
14 |
$5.42 |
| A4566 |
Shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment |
19 |
19 |
$0.00 |
| 97602 |
|
76 |
73 |
$0.00 |
| 15850 |
|
30 |
30 |
$0.00 |
| 99348 |
|
90 |
90 |
$0.00 |
| 36416 |
|
72 |
72 |
$0.00 |
| 2010F |
|
119 |
109 |
$0.00 |
| S0630 |
Removal of sutures; by a physician other than the physician who originally closed the wound |
14 |
14 |
$0.00 |